Test Price
450 AED✅ Home Collection Available
Cytokeratin 7 (CK‑7) Immunohistochemistry Test in UAE | 450 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
- Premium Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval (Archival tissue specimen; mobile phlebotomy disabled for safety).
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation by a DHA‑licensed pathologist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Cytokeratin 7 (CK‑7) immunohistochemistry test is a high‑precision tissue‑based assay that helps oncologists and surgical pathologists differentiate adenocarcinoma origins. It is a core marker in tumor profiling panels, guiding treatment decisions when a cancer of unknown primary is suspected or when sub‑classifying lung adenocarcinomas.
| Feature | Our CK‑7 IHC Service | Closest Alternative |
|---|---|---|
| Methodology | Immunohistochemistry (IHC) with validated monoclonal anti‑CK‑7, DAB chromogen detection on FFPE sections | Standard Hematoxylin & Eosin (H&E) morphology |
| Diagnostic Specificity | High – delineates CK‑7‑positive adenocarcinoma lineages (lung, breast, ovary, upper GI) | Lower – only suggests differentiation, not lineage |
| Turnaround Time | Tissue biopsy: 5 days; Large/complex: 7 days | 3–5 days |
| Price (AED) | 450 | ~350 |
| Accreditation | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) & DHA Facility No. 1143 | General laboratory licensure |
Physician Insight & Safety Protocols
The CK‑7 marker is a valuable tool in our diagnostic arsenal for identifying primary tumor sites. However, it must always be interpreted in the context of full clinical and radiological findings. Our team is dedicated to providing accurate and timely results to support your oncologist's treatment plan.
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology (DHA Registration ID: 61713011)
Clinical Advisory: Medication Continuation
⚠️ Do Not Discontinue Prescribed Medication
Always consult your treating physician before making any changes to your medication regimen. Abrupt discontinuation may lead to adverse health outcomes.
Safety & Exclusion Criteria
- Exclusion: patients with coagulopathy or uncontrolled bleeding who cannot safely undergo biopsy.
- Exclusion: insufficient tissue or inability to provide a formalin‑fixed paraffin‑embedded block.
- Post‑biopsy red flags: persistent bleeding, increasing pain, redness, swelling, pus, or fever.
- Seek emergency care immediately if you develop high fever, shortness of breath, or sudden worsening of symptoms.
Patient FAQ & Clinical Guidance
1. What is the CK‑7 (Cytokeratin 7) test used for?
CK‑7 immunohistochemistry helps distinguish adenocarcinoma primary sites including lung, breast, ovary, and upper gastrointestinal tract. It is a core marker in tumor profiling panels, guiding oncologists when a cancer of unknown primary is suspected or when sub‑classifying lung adenocarcinomas.
2. How should I prepare for the CK‑7 biopsy and test?
You need not fast; provide biopsy report, exact site, and clinical history for accurate interpretation. Your treating physician will obtain a tissue specimen (biopsy) – the sample must be submitted in 10% formal‑saline or as a formalin‑fixed paraffin‑embedded block at room temperature, together with the original histopathology report and details of the biopsy site. No special patient preparation is required beyond what your doctor advises for the biopsy itself.
3. Is the CK‑7 test covered by UAE health insurance?
We quickly verify direct billing with UAE insurers via WhatsApp +971 54 548 8731 to ensure DHA‑compliant coverage. Our billing team confirms eligibility under your plan before the test; we work with all major UAE insurers and provide direct submission when applicable. For individual policy details, contact us on WhatsApp.
UAE Regulatory & Data Privacy Adherence
Your Data, Your Trust
We fully comply with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical data handling and patient consent procedures adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability. Your health information is encrypted, access‑controlled, and never shared without explicit consent.
Clinical & Logistical Metadata
| Test Name | Cytokeratin 7 (CK‑7) Immunohistochemistry |
| Price (AED) | 450 |
| Turnaround Time | 5–7 business days (depending on tissue complexity) |
| Sample Type / Matrix | Formalin‑Fixed Paraffin‑Embedded (FFPE) Tissue Block / Archival Biopsy Slides |
| Methodology Used | Immunohistochemistry (IHC) with monoclonal anti‑CK‑7 and DAB chromogen detection on FFPE sections |
| ICD‑10‑CM Code | C80.1 (Malignant neoplasm without specification of site) |
| LOINC Code | 21528‑3 (Cytokeratin 7 [Presence] in Tissue) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians